gms | German Medical Science

90. Versammlung des Vereins Rhein-Mainischer Augenärzte

Verein Rhein-Mainischer Augenärzte

04.11.2017, Marburg

Article

Send article

Retinal toxicity of medical devices

Meeting Abstract

Search Medline for

  • K. Januschowski - Knappschaftskrankenhaus Sulzbach; Universitäts-Augenklinik Tübingen
  • C. Irigoyen - Ophthalmology Department, Donostia University Hospital, Donostia-San Sebastián, Spanien
  • J. C. Pastor - IOBA, Eye Institute, University of Valladolid, Spanien; Department of Ophthalmology, Hospital Clinico Universitario, Valladolid, Spanien; Oftared, Red Temática de Investigacion en Oftalmologia del Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Madrid, Spanien; Centro en Red de Terapia Celular y Medicina Regenerativa de Castilla y León, Valladolid, Spanien
  • G. K. Srivastavad - Centro en Red de Terapia Celular y Medicina Regenerativa de Castilla y León, Valladolid, Spanien
  • M. R. Romano - Department of Biomedical Sciences, Humanitas University, Milan, Italien; Eye Center, Humanitas Gavazzeni, Humanitas clinic Gavazzeni, Bergamo, Italien
  • H. Heimann - Centre for Ophthalmology, Royal Liverpool University Hospital, Liverpool, Großbritannien
  • P. Stalmans - Department of Ophthalmology, University Hospital Leuven, Belgien
  • K. van Keer - Department of Ophthalmology, University Hospital Leuven, Belgien
  • K. Boden - Knappschaftskrankenhaus Sulzbach
  • P. Szurman - Knappschaftskrankenhaus Sulzbach; Universitäts-Augenklinik Tübingen

Verein Rhein-Mainischer Augenärzte. 90. Versammlung des Vereins Rhein-Mainischer Augenärzte. Marburg, 04.-04.11.2017. Düsseldorf: German Medical Science GMS Publishing House; 2017. Doc35

doi: 10.3205/17rma35, urn:nbn:de:0183-17rma358

Published: November 3, 2017

© 2017 Januschowski et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.

Outline

Text

Retinal toxicity/biocompatibility of medical devices in direct contact with the retina is an important subject for clinicians and scientists. The past has taught us multiple times that there is a significant lack of safety associated with severe loss of vision in affected patients. In this review we want to classify medical products that are used in the back of the eye, describe recent examples of toxicity, critically reflect the regulations that exist and suggest improvements that can be done to ensure patient safety without hindering innovation.